Effects of estradiol-drospirenone on ocular and nasal functions in postmenopausal women


ÇOKSUER H., ÖZCURA F. , OĞHAN F. , Haliloglu B., ÇOKSUER C.

CLIMACTERIC, vol.14, no.4, pp.482-487, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.3109/13697137.2010.539724
  • Title of Journal : CLIMACTERIC
  • Page Numbers: pp.482-487
  • Keywords: HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ANGELIQ, DRY EYE, OCULAR DISEASE, NASAL AIRFLOW, HORMONE REPLACEMENT THERAPY, DRY EYE, LENS OPACITIES, RHINOMANOMETRIC OUTCOMES, REPRODUCTIVE FACTORS, MG DROSPIRENONE, TEAR FUNCTION, ESTROGEN, MENOPAUSE, AGE

Abstract

Background Hormones may have an impact on the incidence and course of dry-eye syndrome, and also nasal obstruction, especially in postmenopausal women. The aim of this study was to investigate the effects of drospirenone 2 mg + estradiol 1 mg (Angeliq (R), Bayer AG, Berlin, Germany) on ocular functions and nasal airflow in postmenopausal women.